The fact that Mine and colleagues [68] validated the COX6c/HMGIC translocation in uterine myomas suggested that the fusion partner COX6c gives rise to the detachment of the DNA-binding domains of HMGIC from the spacer and the acidic carboxyl-terminal regulatory domain, thereby promoting tumor growth. Here, COX6C is linked to neoplasm.